Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
22.39
-0.71 (-3.05%)
Mar 31, 2025, 9:44 AM EDT - Market open
KNSA Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$37.17
Upside
+66.05%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +78.69% | Mar 13, 2025 |
JP Morgan | JP Morgan | Buy Maintains $39 → $40 | Buy | Maintains | $39 → $40 | +78.69% | Nov 5, 2024 |
Evercore ISI Group | Evercore ISI Group | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +56.35% | Oct 30, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +78.69% | Sep 13, 2024 |
Wedbush | Wedbush | Buy Maintains $30 → $34 | Buy | Maintains | $30 → $34 | +51.89% | Jul 23, 2024 |
Wells Fargo | Wells Fargo | Buy Initiates $34 | Buy | Initiates | $34 | +51.89% | May 3, 2024 |
JP Morgan | JP Morgan | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +34.02% | May 1, 2024 |
Evercore ISI Group | Evercore ISI Group | Buy Maintains $25 → $30 | Buy | Maintains | $25 → $30 | +34.02% | Apr 24, 2024 |
Wedbush | Wedbush | Buy Maintains $23 → $25 | Buy | Maintains | $23 → $25 | +11.68% | Jan 2, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $22 → $32 | Strong Buy | Maintains | $22 → $32 | +42.95% | Jul 26, 2023 |
JP Morgan | JP Morgan | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | -10.65% | Mar 9, 2023 |
B of A Securities | B of A Securities | Strong Buy Maintains $37 → $34 | Strong Buy | Maintains | $37 → $34 | +51.89% | Dec 29, 2021 |
B of A Securities | B of A Securities | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +11.68% | Apr 1, 2020 |
JMP Securities | JMP Securities | Buy Maintains $44 → $35 | Buy | Maintains | $44 → $35 | +56.35% | Aug 14, 2019 |
JMP Securities | JMP Securities | Buy Maintains $33 → $44 | Buy | Maintains | $33 → $44 | +96.56% | Sep 17, 2018 |